Correlation Between Macquarie and Imricor Medical

Can any of the company-specific risk be diversified away by investing in both Macquarie and Imricor Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Macquarie and Imricor Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Macquarie Group and Imricor Medical Systems, you can compare the effects of market volatilities on Macquarie and Imricor Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Macquarie with a short position of Imricor Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Macquarie and Imricor Medical.

Diversification Opportunities for Macquarie and Imricor Medical

0.36

Correlation Coefficient

Macquarie  Imricor Medical

Weak diversification

The 3 months correlation between Macquarie and Imricor is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Macquarie Group and Imricor Medical Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imricor Medical Systems and Macquarie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Macquarie Group are associated (or correlated) with Imricor Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imricor Medical Systems has no effect on the direction of Macquarie i.e., Macquarie and Imricor Medical go up and down completely randomly.

Pair Corralation between Macquarie and Imricor Medical

Assuming the 90 days trading horizon Macquarie Group is expected to under-perform the Imricor Medical. But the stock apears to be less risky and, when comparing its historical volatility, Macquarie Group is 3.65 times less risky than Imricor Medical. The stock trades about -0.16 of its potential returns per unit of risk. The Imricor Medical Systems is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  131.00  in Imricor Medical Systems on December 4, 2024 and sell it today you would earn a total of  27.00  from holding Imricor Medical Systems or generate 20.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Macquarie Group  vs.  Imricor Medical Systems

Macquarie Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Macquarie Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Macquarie is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Imricor Medical Systems

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Imricor Medical Systems are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Imricor Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Macquarie and Imricor Medical

The main advantage of trading using opposite Macquarie and Imricor Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Macquarie position performs unexpectedly, Imricor Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imricor Medical will offset losses from the drop in Imricor Medical's long position.

The idea behind Macquarie Group and Imricor Medical Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.